广济药业：拟对生物研究院减少注册资本2200万元

Core Viewpoint - Guangji Pharmaceutical (000952.SZ) announced a capital reduction for its wholly-owned subsidiary, the Biological Research Institute, from RMB 50 million to RMB 28 million, reflecting strategic planning and operational needs [1] Group 1 - The registered capital of the Biological Research Institute was initially RMB 50 million, with a monetary contribution of RMB 24.5996 million made as of the announcement date [1] - The company plans to reduce the registered capital by RMB 22 million, resulting in a new registered capital of RMB 28 million, subject to final registration with the industrial and commercial authorities [1] - The company will maintain 100% ownership of the Biological Research Institute, ensuring that the consolidation scope of the company's financial statements remains unchanged [1] Group 2 - The board of directors has authorized relevant personnel to handle all matters related to this capital reduction, including determining the reduction plan and processing the necessary changes with the industrial and commercial authorities [1]